PAL S. (2013). EVALUATION OF CYSTATIN C AS AN EARLY MARKER OF RENAL IMPAIRMENT IN DIABETIC AND HYPERLIPIDAEMIC PATIENTS. World Research Journal of Medical Science, 1 (1), 13-17.